tim hickling: contribution of ex vivo assays to immunogenicity risk assessment
Published 7 years ago • 350 plays • Length 36:50Download video MP4
Download video MP3
Similar videos
-
35:21
tim hickling: applying in vitro immunogenicity assays to predict clinical immunogenicity
-
33:11
tim hickling: application of immunogenicity prediction and mitigation for biotherapeutic development
-
52:05
timothy hickling: immunogenicity of biotherapeutics: why do we care and where do we stand
-
37:51
bonnie rup: unwanted immunogenicity risk in biotherapeutic discovery and development
-
25:47
heather hinton: pre clinical risk assessment technologies
-
3:35
intel based intelligent analyzer express(iax)-evalyndx
-
2:25
mcg scientists find new target in fight against heart disease
-
24:40
antibodies in research: how does immunohistochemistry work?
-
14:24
the finance of immunogenicity
-
51:40
valerie quarmby: assessing immunogenicity risk in biotherapeutic development
-
41:23
jochem gokemeijer: immunogenicity risk assessment tool box for biologics drug development
-
5:59
evaluating immunogenicity risk of complex peptide products
-
16:08
andrew isidoridy: evaluating immunogenicity risk of complex peptide products
-
29:19
sophie tourdot: non-clinical immunogenicity risk assessment of therapeutic proteins
-
36:04
daron forman: the use of immunogenicity risk assessment tools for lead optimization of biologics
-
32:21
jeremy fry: an integrated approach to managing immunogenicity risk and drug immune modulation
-
29:40
jeremy fry: an integrated approach to managing immunogenicity risk and drug immune modulation
-
28:22
erik meyer: therapeutic immunogenicity: target interference and cut point evaluation
-
56:55
jeremy fry: tools and technologies for immunogenicity risk management
-
51:13
jeremy fry: an integrated approach to managing immunogenicity risk and drug immune modulation